Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03230318
Brief Title: Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma (FIDES-01)

First Submitted : July 24, 2017
First Submitted that Met QC Criteria : July 24, 2017
First Posted : July 26, 2017

Last Update Submitted that Met QC Criteria : January 29, 2021
Last Update Posted : February 1, 2021